BioMarin Pharmaceutical Inc. buy Raymond James
Start price
03.09.25
/
50%
€51.00
Target price
03.09.26
€73.07
Performance (%)
-10.98%
Price
12.12.25
€45.40
Summary
This prediction is currently active. The price of BioMarin Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.98%. This prediction currently runs until 03.09.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.003% | -1.003% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Raymond_James for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $85.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Raymond_James for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€63.66
10.10.24
10.10.24
€72.21
10.10.25
10.10.25
-28.37%
11.10.25
11.10.25
